Effect and Safety of Pioglitazone-Metformin Tablets in the Treatment of Newly Diagnosed Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease in Shaanxi Province: A Randomized, Double-Blinded, Double-Simulated Multicenter Study

Table 3

Incidence of adverse events in each group.

Adverse events	Metformin		Pioglitazone + metformin		Fisher
	Frequency	Rate	Frequency	Rate
Total adverse events	8	13%	7	8.33%	0.5585
Adverse events related to study	6	10.00%	5	6.67%	0.743
Adverse events not related to study	3	5.00%	2	3.33%	1
Serious adverse events	1	1.67%	1	1.67%	1

.